- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
EXHIBIT 23.1
CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS
We have issued our report dated March 7, 2003, accompanying the consolidated balance sheet of Interleukin Genetics, Inc. and subsidiary as of December 31, 2002, and the related consolidated statements of operations, shareholders’ (deficit) equity and comprehensive loss, and cash flows for the year then ended in the Annual Report of Interleukin Genetics, Inc. on Form 10-K for the year ended December 31, 2002. We hereby consent to the incorporation by reference of said report in the registration statements on Form S-3 (Nos. 333-83631, 333-53558, 333-56558 and 333-101088) and on Form S-8 (Nos. 333-37343, 333-67147, 333-32538 and 333-62638) of Interleukin Genetics, Inc.
| /s/ GRANT THORNTON LLP |
Boston, Massachusetts
April 11, 2003